MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-33-0166786
Veecap Pharmaceuticals Private Limited
Veecap Pharmaceuticals Private Limited - food and beverages in Bhayander, Maharashtra, India. Directors, charges & compliance details.
Revenue · FY 2025
₹13.25 Lakh
▼ 25% YoY
Net profit · FY 2025
₹11,496
Net margin 0.9%
EBITDA · FY 2025
₹17,748
EBITDA margin 1.3%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
6 yrs
Est. 2020
Directors on board
2
As per MCA filings
Last financials
Mar 2025
Balance sheet date
About Veecap Pharmaceuticals Private Limited
Data last updated:
Veecap Pharmaceuticals Private Limited is a private limited company based in Bhayander, Maharashtra, India. It operates in the artificial fibres segment of the food and beverages sector. It was incorporated on 14 January 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24304MH2020PTC335980.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Bindu and Surta Devi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Bhayander, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹13.25 Lakh, a decline of 25% compared to the previous year. For the same year it recorded a net profit of ₹11,496 (net margin 0.9%) and EBITDA of ₹17,748 (EBITDA margin 1.3%). Revenue has grown at a compounded annual rate (CAGR) of 45% over three years.
Veecap Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-33-0166786).
Company details
CIN U24304MH2020PTC335980
Registration Number 335980
Incorporation Date 14 January 2020
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-MH-33-0166786
Key People
Bindu Director Surta Devi Director Recognitions & Rankings of Veecap Pharmaceuticals
Contact details
Veecap Pharmaceuticals Private Limited's registered office is in Bhayander, Maharashtra.
- Registered AddressFlat No. B/111 Lovely Palace No.2 Chs Ltd Kharigaon B.P Cross Road Near Sagar Ap, T, Bhayander, Maharashtra, India – 401105
- IndustryFood And Beverages, Artificial Fibres, Manufacturing
Comprehensive company report
Veecap Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Veecap Pharmaceuticals is trade. In detail, this covers retail trading and wholesale trading. 2 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading | |
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Veecap Pharmaceuticals Private Limited, buy the company report.
Financials of Veecap Pharmaceuticals Private Limited
FY 2025 filings availableVeecap Pharmaceuticals Private Limited reported revenue of ₹13.25 Lakh (down 25% YoY) for FY 2025.
Revenue · FY 2025
₹13.25 Lakh ▼ 25%
Net profit · FY 2025
₹11,496 margin 0.9%
EBITDA · FY 2025
₹17,748 margin 1.3%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 25%
3 years · compounded
▲ 45%
EBITDA CAGR growth
1 year
▼ 17%
3 years · compounded
▲ 92%
Revenue fell 25% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 45%. EBITDA fell 17% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹17,748 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹11,496 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.3% | ||||
| Net Profit Margin | 0.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Veecap Pharmaceuticals Private Limited, buy the company report.
Board of directors of Veecap Pharmaceuticals Private Limited
Veecap Pharmaceuticals has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bindu | Director | 14 Jan 2020 | 6 Years 9 Months | Current |
| Surta Devi | Director | 14 Jan 2020 | 6 Years 9 Months | Current |
Legal cases
No court or tribunal cases involving Veecap Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Veecap Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Veecap Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Veecap Pharmaceuticals Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Bindu was appointed as Director on 14 Jan 2020.
AGM
Veecap Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Veecap Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Appointed
Bindu was appointed as Director.
Appointed
Surta Devi was appointed as Director.
Incorporation
14 Jan 2020
Veecap Pharmaceuticals Private Limited was registered on 14 Jan 2020 with Roc Mumbai & aged 6 years 9 months as per MCA records.
Frequently asked questions
Veecap Pharmaceuticals is an active private limited company based in Bhayander, Maharashtra, India. The company works in artificial fibres, within the food and beverages industry. It was incorporated on 14 January 2020 (6+ years old) and is registered under CIN U24304MH2020PTC335980.
Veecap Pharmaceuticals has 2 current directors:
- Bindu - Director
- Surta Devi - Director
The latest financial statements of Veecap Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The CIN (Corporate Identification Number) of Veecap Pharmaceuticals is U24304MH2020PTC335980. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Veecap Pharmaceuticals was incorporated on 14 January 2020, making it 6+ years old. It is registered with the Registrar of Companies, Mumbai.
Bindu was appointed as Director on 14 Jan 2020. Surta Devi was appointed as Director on 14 Jan 2020.
Yes, Veecap Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-33-0166786).
The registered office of Veecap Pharmaceuticals is at Flat No. B111 Lovely Palace No.2 Chs Ltd Kharigaon B.P Cross Road Near Sagar Ap, T, Bhayander, Maharashtra, India – 401105.
Veecap Pharmaceuticals operates in the food and beverages industry, in the artificial fibres segment.
Veecap Pharmaceuticals can be reached at its registered office: Flat No. B111 Lovely Palace No.2 Chs Ltd Kharigaon B.P Cross Road Near Sagar Ap, T, Bhayander, Maharashtra, India – 401105.